email@mymsaa.org
Multiple Sclerosis Association of America Logo
Link to FaceBook Link to Twitter Link to YouTube Link to Pinterest
Improving Lives Today!
donate
About MS
MS Overview
Newly Diagnosed
Symptoms
Treatments
Online Webinars & Videos
MSAA Publications
Prescription Assistance Programs
Toll-Free Helpline
Clinical Trial Information
Información en Español
FAQs



Home > About MS > Clinical Trials Resource Center


Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine

Multiple Sclerosis Clinical Trials


A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Investigational Site Number 840077 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Birmingham : Alabama Neurology Associates

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Birmingham : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Birmingham : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Birmingham : University of Alabama at Birmingham Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cullman : Investigational Site Number 840007 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Cullman : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cullman : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Cullman : Teva Investigational Site 10329

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Cullman : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Cullman : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Cullman : North Central Neurology Associates, PC

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Huntsville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Arizona

Phoenix : St. Joseph’s Hospital and Medical Center

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Gilbert : Neurological Physicians of Arizona/Clinical Research Advantage

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Gilbert : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Gilbert : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Gilbert : Neurological Physicians of Arizona/Clinical Research Advantage

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Gilbert : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Glendale : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Phoenix : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Phoenix : HOPE Research Institute Updated

A clinical research study of Tcelna and Placebo

Phoenix : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Phoenix : Investigational Site Number 840087 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Phoenix : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Phoenix : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Scottsdale : Investigational Site Number 840080 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Scottsdale : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Scottsdale : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Sun City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tempe : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Tucson : NSS Clinical Research, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Tucson : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Tucson : Northwest NeuroSpecialists, LLC Updated

A clinical research study of Tcelna and Placebo

Tucson : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Tucson : Northwest NeuroSpecialists, PLLC

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tucson : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Tucson : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tucson : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Tucson : Teva Investigational Site 10342

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tucson : NSS Clinical Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Tucson : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tucson : Northwest NeuroSpecialists, PLLC

Patients are needed to participate in a clinical research study of MSDX Complex-1 Biomarker test to evaluate Relapsing Remitting Multiple Sclerosis

Arkansas

Phoenix : Investigational Site Number 840021 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

California

Berkeley : Jordan Research and Education Institute

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Los Angeles : University of Southern California - Keck School of Medicine

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Arcadia : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Berkeley : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Berkeley :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Berkeley :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Davis : University of California Davis Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Fresno : Victoria Walton, MD

A clinical study for patients with Multiple Sclerosis

Fresno :

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis or Urinary Bladder Diseases

Fresno :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Fresno : Teva Investigational Site 10310

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Fullerton : Fullerton Neurology and Headache Center

A clinical study for patients with Multiple Sclerosis

Fullerton : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Fullerton : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Fullerton : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

La Jolla : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Long Beach : Investigational Site Number 840108 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Long Beach : Collaborative Neuroscience Network, Inc.

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Long Beach : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Los Angeles : Sanguine Biosciences Updated

A clinical study for patients with Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease or Huntington's Disease

Los Angeles : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Los Angeles : Keck School of Medicine of the University of Southern Calfornia

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Los Angeles : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Los Angeles : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Los Angeles : Sanguine Biosciences Updated

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : Univeristy of California Los Angeles Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Newport Beach : Multiple Sclerosis Center of California & Research

A clinical study for patients with Multiple Sclerosis

Newport Beach : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Newport Beach : Investigational Site Number 840014 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Newport Beach : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newport Beach : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Oceanside : Investigational Site Number 840019 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Oceanside : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Oceanside : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Rancho Mirage : California Stem Cell Treatment Center

A clinical trial to evaluate treatments using Administration of autologous adipose derived SVF

Sacramento : Sutter Institute for Medical Research

A clinical study for patients with Multiple Sclerosis

Sacramento : University of California Davis Medical Center

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Sacramento : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Sacramento : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Sacramento : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Sacramento :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sacramento : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

San Diego : Novartis Investigative Site

A clinical research study of VAY736 and Placebo for the treatment of Relapse Remitting Multiple Sclerosis

San Francisco : University of California San Francisco

A clinical study for patients with Multiple Sclerosis

San Francisco : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

San Francisco : University of California at San Francisco (UCSF)

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

San Francisco : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Stanford : Stanford University Medical Center

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Temecula : Viking Clinical Research Center

A clinical study for patients with Multiple Sclerosis

Torrance : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Torrance : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Walnut Creek : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Colorado

Boulder : Alpine Clinical Research Center

Investigational Medication for people with Relapsing Remitting Multiple Sclerosis

Boulder : Alpine Clinical Research Center

New Investigational Medication for Relapsing Remitting Multiple Sclerosis (RRMS)

Boulder : Alpine Clinical Research Center

New Investigational Medication for Relapsing Remitting Multiple Sclerosis (RRMS) who have had a documented relapse in the last year

Boulder : Alpine Clinical Research Center

New Investigational Medication for Secondary Progressive Multiple Sclerosis

Boulder : Alpine Clinical Research Center

Newly Approved Medication for Multiple Sclerosis

Aurora : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Aurora : University of Colorado Denver

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Aurora : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Aurora : University of Colorado Denver

A clinical trial to evaluate treatments using ACTHAR Gel (ACTH) and IV steroids with oral taper for patients with Multiple Sclerosis

Aurora : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Aurora : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Aurora : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Aurora : Teva Investigational Site 10307

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Aurora : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Aurora : University of Colorado Hospital, Aschutz Inpatient Pavilion

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Basalt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Basalt : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Boulder : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Boulder : Investigational Site Number 840097 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Boulder : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Boulder : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Boulder : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Denver : Investigational Site Number 840046 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Denver : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Denver : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Denver : University of Colorado Denver Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Englewood : Colorado Neurological Institute

A clinical study for patients with Multiple Sclerosis

Englewood : Investigational Site Number 840016 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Englewood : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Englewood : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Englewood : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Fort Collins : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Fort Collins : Investigational Site Number 840094 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Fort Collins : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Fort Collins : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Fort Collins : Teva Investigational Site 10332

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Fort Collins : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Fort Collins : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Fort Collins : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Connecticut

New London : Coastal Connecticut Research, LLC

Are You Currently Being Treated for a Relapsing Form of Multiple Sclerosis?

Danbury : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Danbury : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Danbury : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Derby : Multiple Sclerosis Treatment Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Derby : Multiple Sclerosis Treatment Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Derby : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Fairfield : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Fairfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Fairfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Hartford : The Mandell Center for Multiple Sclerosis

Patients are needed to participate in a clinical research study evaluating Avonex for the treatment of Multiple Sclerosis

New Haven : Institute for Neurodegenerative Disorders

Patients are needed to participate in a clinical research study of [18F]Florbetapir and PET imaging to evaluate Multiple Sclerosis

New London : Coastal Connecticute Research, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

New London : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

New London : Coastal Connecticute Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Delaware

Dover : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Dover : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Newark : Christiana Care Health Services

A clinical study for patients with Multiple Sclerosis

Newark : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Newark : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newark : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

District of Columbia

Washington : Georgetown University Hospital

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Washington : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Washington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Washington : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Washington : Georgetown University Hospital

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Washington : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Washington : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Florida

Bradenton : Bradenton Research Center, Inc.

Multiple Sclerosis and Spasticity

Bradenton : Bradenton Research Center, Inc.

Taking Gilenya for Multiple Sclerosis?

Tampa : Axiom Clinical Research of Florida

A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early Stages of Treatment for Relapsing Remitting Multiple Sclerosis

Tampa : Axiom Clinical Research of Florida

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

Tampa : Axiom Clinical Research of Florida

An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis

Tampa : Meridien Research

Multiple Sclerosis Medication Study

Tampa : Meridien Research

Multiple Sclerosis Medication Study

Tampa : Meridien Research

Oral Multiple Sclerosis Medication Study

Atlantis : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Bradenton : Brandenton Neurology, Inc.

A clinical study for patients with Multiple Sclerosis

Bradenton : Bradenton Research Center, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Bradenton : Investigational Site Number 840024 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Bradenton : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Bradenton : Bradenton Research Center, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Gainesville : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Hialeah : Investigational Site Number 840104 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Hollywood : Sunrise Clinical Research, Inc.

A clinical study for patients with Multiple Sclerosis

Hollywood : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Jacksonville : University of Florida

A clinical study for patients with Multiple Sclerosis

Jacksonville : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Jacksonville : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Jacksonville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Jacksonville : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Jacksonville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Lighthouse Point : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Maitland : Neurology Associates, PA

A clinical study for patients with Multiple Sclerosis

Maitland : Neurology Associates, P.A. Updated

A clinical research study of Tcelna and Placebo

Maitland : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Maitland : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Maitland : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Melbourne : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Miami : Advanced Medical Pain Management & Research Clinic

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Miami : University of Miami Updated

A clinical research study of Tcelna and Placebo

Miami : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Miami : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Miami : University of Miami Miller School of Medicine

A Phase 2 clinical study for patients with Relapsing Remitting MS, Secondary Progressive MS or Primary Progressive MS

Miami : Teva Investigational Site 10316

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Miami Lakes : Investigational Site Number 840101 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Naples : Collier Neurologic Specialists, LLC Updated

A clinical research study of Tcelna and Placebo

Naples : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Naples : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

North Palm Beach : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Orlando : Neurological Services of Orlando Updated

A clinical research study of Tcelna and Placebo

Orlando : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Ormond Beach : Neurology Associates of Ormond Beach

A clinical study for patients with Multiple Sclerosis

Ormond Beach : Neurology Associates of Ormond Beach

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Ormond Beach : Investigational Site Number 840011 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Ormond Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ormond Beach : Neurology Associates of Ormond Beach

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Ormond Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Plantation : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Pompano Beach : Neurological Associates

A clinical study for patients with Multiple Sclerosis

Pompano Beach : Investigational Site Number 840081 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Pompano Beach : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Pompano Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Pompano Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Ponte Vedra Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Port Charlotte : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Port Charlotte : Neurostudies, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Port Charlotte : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Port Orange : Progressive Medical Research

A clinical study for patients with Multiple Sclerosis

Port Orange : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Sarasota : Roskamp Institute

A clinical study for patients with Multiple Sclerosis

Sarasota : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Sarasota : Investigational Site Number 840059 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Sarasota : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Sarasota : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Sarasota : Teva Investigational Site 10308

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sarasota : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Sarasota : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Petersburg : Suncoast Neuroscience Associates, Inc

A clinical study for patients with Multiple Sclerosis

St. Petersburg : Investigational Site Number 840008 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

St. Petersburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

St. Petersburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

St. Petersburg : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Sunrise : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sunrise : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Tallahassee : AMO Corporation

A clinical study for patients with Multiple Sclerosis

Tallahassee : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tallahassee : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Tallahassee : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tallahassee : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Tallahassee : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tampa : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Tampa : Meridien Research Updated

A clinical research study of Tcelna and Placebo

Tampa : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Tampa : USF Carol and Frank Morsani Center for Advanced Healthcare

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tampa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Tampa : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tampa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tampa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tampa : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tampa : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Tampa : Teva Investigational Site 10323

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tampa : University of South Florida

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Tampa : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Tampa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Vero Beach : MS Center of Vero Beach

A clinical study for patients with Multiple Sclerosis

Vero Beach : Vero Beach Neurology Updated

A clinical research study of Tcelna and Placebo

Vero Beach : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Vero Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

West Palm Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

West Palm Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

West Palm Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Weston : Cleveland Clinic Florida

A clinical study for patients with Multiple Sclerosis

Weston :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Weston :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Georgia

Atlanta : NeuroTrials Research

Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

Atlanta : Shepherd Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Atlanta : Emory University

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Atlanta : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Atlanta : Shepherd Center Updated

A clinical research study of Tcelna and Placebo

Atlanta : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Atlanta : Investigational Site Number 840002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Atlanta : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Atlanta : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Atlanta : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Atlanta : Emory University

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Atlanta : Shepherd Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Atlanta : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Atlanta : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Atlanta : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Atlanta : Emory University Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Columbus : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Decatur : Neurostudies

A clinical study for patients with Multiple Sclerosis

Decatur : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Macon : Investigational Site Number 840075 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Savannah : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Hawaii

Honolulu : Leo Maher, MD

A clinical study for patients with Multiple Sclerosis

Illinois

Elk Grove Village : Alexian Brothers Hospital Network

A 6 month, randomized, active comparator, open-label, multi-center study to evaluate patient outcomes, safety and tolerability of Fingolimod (FTY720) 0.5mg/day in patients with relapsing remitting MS who are candidates for MS therapy change from previous disease modifying therapy (EPOC).

Flossmoor : South Suburban Neurology

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Barrington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Champaign : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Chicago : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Chicago : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Chicago : Teva Investigational Site 10350

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chicago : University of Chicago

Patients are needed to participate in a clinical research study evaluating Tysabri for the treatment of Multiple Sclerosis

Elk Grove Village : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Evanston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Evanston : Northwestern University Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Flossmoor : South Suburban Neurology

A clinical study for patients with Multiple Sclerosis

Flossmoor : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Flossmoor : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Flossmoor : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Lake Barrington : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Lake Barrington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lille Cedex : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Northbrook : Consultants In Neurology, Ltd. Updated

A clinical research study of Tcelna and Placebo

Northbrook : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Northbrook : Teva Investigational Site 10343

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Northbrook : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Peoria : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Peoria : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Indiana

Anderson : Community Clinical Research Center

A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early Stages of Treatment for Relapsing Remitting Multiple Sclerosis (PREFERMS)

Anderson : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Elkhart : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Fort Wayne : Fort Wayne Neurological Center Updated

A clinical research study of Tcelna and Placebo

Fort Wayne : Investigational Site Number 840012 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Fort Wayne : Teva Investigational Site 10339

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Indianapolis : Josephson Wallack Munshower Neurology, PC Updated

A clinical research study of Tcelna and Placebo

Indianapolis : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Indianapolis : Investigational Site Number 840010 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Indianapolis : Indiana University

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Indianapolis : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Indianapolis : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Indianapolis : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Indianapolis : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Indianapolis : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Indianapolis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Indianapolis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Indianapolis : Indiana University Health Neuroscience Center

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Merrillville : Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Wayne : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Iowa

Des Moines : Mercy Ruan Neurology Clinic Res Ct.

A clinical study for patients with Multiple Sclerosis

Des Moines : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

West Des Moines : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kansas

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Kansas City : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Kansas City : University of Kansas Medical Center Updated

A clinical research study of Tcelna and Placebo

Kansas City : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Kansas City : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Kansas City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kansas City : University of Kansas Medical Center Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Kansas City : University of Kansas Medical Center

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Lenexa : Mid America Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Lenexa : Rowe Neurology Institute

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Lenexa : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Lenexa : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Lenexa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lenexa : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Lenexa : Teva Investigational Site 10348

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Lenexa : Rowe Neurology Institute

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Lenexa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Overland Park : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Topeka : Precise Clinical Research

A clinical study for patients with Multiple Sclerosis

Topeka : Cotton O'Neil Clinical Research Institute

A clinical study for patients with Multiple Sclerosis

Kentucky

Lexington : University of Kentucky Chandler Medical Center

Help us to make progress in Secondary Progressive MS

Lexington : Associates in Neurology

A clinical study for patients with Multiple Sclerosis

Lexington : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Lexington : Associates in Neurology Updated

A clinical research study of Tcelna and Placebo

Lexington : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Lexington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lexington : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Louisville : Norton Healthcare, Inc.

A clinical study for patients with Multiple Sclerosis

Louisville : Norton Neurology MS Services

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Louisville : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Louisville : Investigational Site Number 840034 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Louisville : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Louisville : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Louisville : Norton Neurology MS Services

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Louisville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Louisiana

Shreveport : Louisiana State University

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Baton Rouge : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Baton Rouge : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Hammond : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Maine

Rockport : Investigational Site Number 840047 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Maryland

Baltimore : University of Maryland

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Annapolis : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Annapolis : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Baltimore : University of Maryland

A clinical study for patients with Multiple Sclerosis

Baltimore : Johns Hopkins

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Baltimore : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Baltimore : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Baltimore : Johns Hopkins University

Patients are needed to participate in a clinical research study evaluating BIIB017 for the treatment of Relapsing Remitting Multiple Sclerosis

Baltimore : Johns Hopkins

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Baltimore : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Bethesda : Bethesda Neurology, LLC

A clinical study for patients with Multiple Sclerosis

Massachusetts

Boston : Brigham Women’s Hospital

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Boston : Caritas St. Elizabeth's Hospital

A clinical study for patients with Multiple Sclerosis

Boston : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Boston : Saint Elizabeth's Medical Center Updated

A clinical research study of Tcelna and Placebo

Boston : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Boston : Teva Investigational Site 10338

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Boston : Call EMD Serono Medical Information for information on recruiting sites

Patients are needed to participate in a clinical research study evaluating Standard Services of Group A (Group A1), Customized Services of Group A (Group A2) and Group B for the treatment of Multiple Sclerosis or Relapsing-Remitting

Boston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Boston : Brigham and Women's Hospital Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Boston : Massachusetts General Hospital Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Boston : Beth Israel Deaconess Medical Center, Center for Life Sciences

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Brookline : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Burlington : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Cambridge : Outcome Sciences, Inc

A clinical trial to evaluate treatments using Cladribine for patients with Multiple Sclerosis

Cambridge : Novartis Investigative Site

Patients are needed to participate in a clinical research study of Fingolimod to evaluate Multiple Sclerosis

Cambridge : Registry participation is worldwide and not limited to this facility; facilities not yet active may enroll upon identification of a patient

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis or Exposure During Pregnancy

Foxboro : Investigational Site Number 840107 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Lexington : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Lexington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Milford : Milford Regional Medical Center

A clinical study for patients with Multiple Sclerosis

Milford : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

New Bedford : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

North Dartmouth : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Quincy : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Springfield : Springfield Neurology Associates, LLC

A clinical study for patients with Multiple Sclerosis

Springfield : Investigational Site Number 840030 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Springfield : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Springfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Springfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Watertown : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Worcester : Fallon Clinic at Worcester Medical Center

A clinical study for patients with Multiple Sclerosis

Worcester : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Worcester : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Worcester : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Worcester : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Michigan

Kalamazoo : Bronson Methodist Hospital

A 12-month, Prospective, Randomized, active-controlled, open-label study to Evaluate the patient retention of Fingolimod vs. approved first-line disease modifying therapies in adults who are in Early stages of treatment for Relapsing remitting multiple sclerosis (PREFERMS)

Ann Arbor : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Clinton Township : Investigational Site Number 840073 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Clinton Township : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Detroit : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Detroit : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Detroit : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Detroit : Henry Ford Health System, Department of Neurology

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Detroit : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Detroit : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Detroit : Wayne State University - University Health Center

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

East Lansing : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Kalamazoo : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Muskegon : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Novi : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Traverse City : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Traverse City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Minnesota

Minneapolis : University of Minnesota

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Edina : Minneapolis Clinic of Neurology

A clinical study for patients with Multiple Sclerosis

Edina : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Golden Valley : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Golden Valley : Investigational Site Number 840098 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Golden Valley : Investigational Site Number 840068 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Golden Valley : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Golden Valley : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Golden Valley : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Minneapolis : Clinical Neuroscience Research Unit, University of Minnesota

A clinical trial seeking patients for a research study for the treatment of Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis or Progressive Relapsing Multiple Sclerosis

Missouri

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Children with and without Multiple Sclerosis or (MS) or Clinically Isolated Syndrome (CIS) are needed for a Washington University research study.

Chesterfield : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Chesterfield : Investigational Site Number 840086 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Columbia : University of Missouri Department of Physical Medicine and Rehabilitation

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Columbia : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Columbia : University of Missouri Department of Physical Medicine and Rehabilitation

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Kansas City : Saint Luke's Hospital

A clinical study for patients with Multiple Sclerosis

Kansas City : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Kansas City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nixa : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

North Kansas City : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Springfield : St.John's Research Institute, Inc

A clinical study for patients with Multiple Sclerosis

St. Louis : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

St. Louis : Investigational Site Number 840058 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

St. Louis : BJC Medical Group (Missouri Baptist Medical Center)

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

St. Louis : Washington University (John L. Trotter MS Center)

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis or Optic Neuritis

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Louis : Washington University School of Medicine in St Louis Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Montana

Great Falls : Benefis Physician Associates

A clinical study for patients with Multiple Sclerosis

Great Falls : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Great Falls : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Great Falls : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nebraska

Lincoln : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Lincoln : Investigational Site Number 840026 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Lincoln : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lincoln : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Omaha : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Nevada

Las Vegas : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Las Vegas : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

New Hampshire

Lebanon : Dartmouth Hitchcock Medical Center

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Lebanon : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Lebanon : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

New Jersey

Freehold : Investigational Site Number 840049 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Freehold : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Freehold : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Marlton : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

New Brunswick : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Newark : UMDNJ

A clinical study for patients with Multiple Sclerosis

Newark : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Newark : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Princeton : GE Healthcare

A Phase 1 clinical study for patients with Evaluate the Safety of GEH120714 (18F) Injection in Healthy Volunteers (HV) and Participants With rrMS.

Teaneck : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Teaneck : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Toms River : Investigational Site Number 840044 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Toms River : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

New Mexico

Albuquerque : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Albuquerque : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

New York

Buffalo : Jacobs Neurological Institute Buffalo General Hospital

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Mineola : Winthrop University Hospital Clinical Trials Center

Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis

New York : Judith Jaffe Multiple Sclerosis Center

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Albany : Neurological Associates of Albany, PC

A clinical study for patients with Multiple Sclerosis

Albany : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Albany : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Albany : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Albany : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Amherst : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Amherst : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Bronx : Montefiore Medical Center Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Buffalo : Buffalo Neuroimaging Analysis Center

A clinical research study for the treatment of Multiple Sclerosis

Buffalo : Investigational Site Number 840064 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Buffalo : Buffalo Neuroimaging Analysis Center

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Buffalo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Buffalo : University at Buffalo, The State University of New York Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Latham : Empire Neurology, PC

A clinical study for patients with Multiple Sclerosis

Latham : Multiple Sclerosis Center of Northeastern New York

A clinical research study of incabotulinumtoxinA and Placebo for the treatment of Muscle Spasticity or Multiple Sclerosis

Latham : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Latham : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Latham : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Latham : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Latham : MS Center of Northeastern NY/Empire Neurology

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

New York : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

New York : Investigational Site Number 840005 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

New York : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

New York : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

New York : Icahn School of Medicine at Mount Sinai

Patients are needed to participate in a clinical research study evaluating Acthar Gel for the treatment of Multiple Sclerosis

New York : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

New York : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

New York : Cornell Medical College Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

New York : Columbia University Medical Center Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Patchogue : South Shore Neurologic Associates

A clinical study for patients with Multiple Sclerosis

Patchogue : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Patchogue : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Patchogue : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Patchogue : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Patchogue : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Patchogue : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Plainview : Island Neurological Associates

A clinical study for patients with Multiple Sclerosis

Plainview : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Plainview : Island Neurological Assoicates, PC Updated

A clinical research study of Tcelna and Placebo

Plainview : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Plainview : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Rochester : University of Rochester Medical Center

A clinical study for patients with Multiple Sclerosis

Rochester : University of Rochester

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Rochester : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Rochester : University of Rochester Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of Lubiprostone and Placebo to evaluate Multiple Sclerosis or Constipation

Rochester : University of Rochester Medical Center

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Schenectady : Investigational Site Number 840071 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Staten Island : Investigational Site Number 840091 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Stony Brook : Stony Brook University

A clinical trial to evaluate treatments using Mindfulness based stress reduction (MBSR) for patients with Multiple Sclerosis

Stony Brook : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Stony Brook : University at Stony Brook, The State University of New York Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Syracuse : Investigational Site Number 840045 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Syracuse : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

White Plains : Burke Rehabilitation Hospital

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

White Plains : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

White Plains : Burke Rehabilitation Hospital

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

North Carolina

Cary : PMG Research of Cary

Nearly 400,000 people in the U.S. have Multiple Sclerosis. Are you one of them?

Chapel Hill : University of North Carolina

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Charlotte : PMG Research of Charlotte

Have you experienced greater disability from your Multiple Sclerosis (MS)?

Charlotte : PMG Research of Charlotte

Multiple Sclerosis (MS) Research Opportunity

Charlotte : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Concord : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Kannapolis : Duke University

The MURDOCK Study Community Registry and Biorepository Primary Progressive Multiple Sclerosis Cohort

Wilmington : PMG Research of Wilmington

Nearly 400,000 people in the U.S. have Multiple Sclerosis. Are you one of them?

Winston-Salem : PMG Research of Winston-Salem

Does your Multiple Sclerosis keep you from walking comfortably?

Winston-Salem : PMG Research of Winston-Salem

Have you been diagnosed with a relapsing form of Multiple Sclerosis?

Winston-Salem : PMG Research of Winston-Salem

Nearly 400,000 people in the U.S. have Multiple Sclerosis. Are you one of them?

Advance : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Advance : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Advance : Teva Investigational Site 10346

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Asheville : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Asheville : Investigational Site Number 840084 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Asheville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Asheville : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Chapel Hill : University of North Carolina at Chapel Hill Department of Neurology

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Chapel Hill : University of North Carolina at Chapel Hill Department of Neurology

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Charlotte : The Neurological Institute, PA

A clinical study for patients with Multiple Sclerosis

Charlotte : Carolinas Medical Center Neurology Updated

A clinical research study of Tcelna and Placebo

Charlotte : PMG Research of Charlotte Updated

A clinical research study of Tcelna and Placebo

Charlotte : The Neurological Institute, PA Updated

A clinical research study of Tcelna and Placebo

Charlotte : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Charlotte : Investigational Site Number 840078 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Charlotte :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Charlotte :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Charlotte : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Charlotte : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Charlotte : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Charlotte : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Charlotte : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlotte : The Neurological Institute, PA

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Durham : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Greensboro : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Greensboro : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Greenville : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Hickory : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

High Point : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Province : Investigational Site Number 840074 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Raleigh : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Raleigh : Investigational Site Number 840042 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Raleigh : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Raleigh : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Raleigh :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Raleigh : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Raleigh : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Raleigh : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Salisbury : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Sanford : Investigational Site Number 840105 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Winston-Salem : PMG Research of Winston-Salem

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Winston-Salem : Investigational Site Number 840090 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Winston-Salem : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Winston-Salem : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Winston-Salem : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Winston-Salem : Teva Investigational Site 10347

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Winston-Salem : PMG Research of Winston-Salem

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Winston-Salem : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

North Dakota

Bismarck : St. Alexius Medical Center New

A research study for patients who have been diagnosed with multiple sclerosis

Fargo : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Grand Forks : Altru Health System/Altru Clinic-Main

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Grand Forks : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Grand Forks : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Ohio

Akron : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Akron : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Akron :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Akron :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Akron : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Akron : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Akron : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Akron : Neurology & Associates, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Akron : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Bellevue : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bellevue : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Bellevue : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Bellevue : Teva Investigational Site 10309

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bellevue : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Canton : Investigational Site Number 840003 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Canton : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Cincinnati : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Cincinnati : University of Cincinnati, Department of Neurology Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cleveland : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Cleveland :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Cleveland :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Cleveland : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Cleveland : Cleveland Clinic Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cleveland : The Cleveland Clinic Foundation

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Columbus : The Ohio State University Medical Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Columbus : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Columbus : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Columbus : Teva Investigational Site 10317

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Columbus : The Ohio State University Medical Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Columbus : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Columbus : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Columbus : Ohio State University Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Dayton : Neurology Specialists, Inc.

A clinical study for patients with Multiple Sclerosis

Dayton : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Dayton : Neurology Specialists, Inc Updated

A clinical research study of Tcelna and Placebo

Dayton : Investigational Site Number 840009 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Dayton : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Dayton : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dayton : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Dayton : Teva Investigational Site 10325

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Dayton : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Dayton : Research site

Patients are needed to participate in a clinical research study to evaluate Relapsing Remitting Multiple Sclerosis

Gahanna : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Toledo : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Toledo : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Toledo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Uniontown : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Uniontown : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Uniontown : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Oklahoma

Oklahoma City : Lynn Health Science Institute

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Oklahoma City : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Oklahoma City : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Oklahoma City : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Oklahoma City : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Oklahoma City : OMRF MS Center of Excellence

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Oklahoma City : Lynn Health Science Institute

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Oklahoma City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Oklahoma City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tulsa : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tulsa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Oregon

Portland : Providence St. Vincent Medical Center

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Clackamas : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Corvallis : The Corvallis Clinic, P.C.

A clinical study for patients with Multiple Sclerosis

Medford : Providence Medical Group - Medford Updated

A clinical research study of Tcelna and Placebo

Medford : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Portland : Providence Multiple Sclerosis Center

A clinical study for patients with Multiple Sclerosis

Portland : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Portland : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Portland : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Portland : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Portland : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Portland : Oregon Health and Science University Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Pennsylvania

Abington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Abington : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Greensburg : Westmoreland Neurology

A clinical study for patients with Multiple Sclerosis

Greensburg : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Greensburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Hershey : Penn State University College of Medicine/MS Hershey Medical Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Hershey : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Monaca : Investigational Site Number 840053 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Monroeville : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Philadelphia : University of Pennsylvania Health System

A clinical study for patients with Multiple Sclerosis

Philadelphia : Thomas Jefferson University

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Philadelphia : University of Pennsylvania Updated

A clinical research study of Tcelna and Placebo

Philadelphia : Teva Investigational Site 10331

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Philadelphia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Pittsburgh : Research Protocol Management Solutions

A clinical study for patients with Multiple Sclerosis

Pittsburgh : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Pittsburgh : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Pittsburgh : University of Pittsburgh Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Tarentum : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Rhode Island

Providence : The Neurology Foundation, Inc.

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Cranston : Investigational Site Number 840072 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Cranston : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Providence : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

South Carolina

Greenville : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Greenville : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Spartanburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Spartanburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Spartanburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tennessee

Franklin : Advanced Neurosciences Institute

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Bristol : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Cordova : Neurology Clinic, P.C.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Cordova : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Cordova : Neurology Clinic, P.C.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Cordova : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Cordova : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Franklin : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Franklin : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Franklin : Teva Investigational Site 10324

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Franklin : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Knoxville : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Knoxville : New Orleans Center for Clinical Research (NOCCR)

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Knoxville : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Knoxville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Knoxville : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Knoxville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nashville : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Nashville : Investigational Site Number 840048 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Nashville : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Nashville : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Nashville : Teva Investigational Site 10318

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nashville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nashville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nashville : Vanderbilt University Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Tullahoma : Investigational Site Number 840035 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Texas

San Antonio : Innovative Clinical Trials

Multiple Sclerosis with Spasticity

San Antonio : Innovative Clinical Trials

Multiple Sclerosis with Spasticity

Austin : Future Search Trials of Neurology, LP

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Austin : Future Search Trials of Neurology, LP

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Colleyville : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Dallas : Baylor Research Institute

A clinical study for patients with Multiple Sclerosis

Dallas : University of Texas Southwestern

A clinical study for patients with Multiple Sclerosis

Dallas : Investigational Site Number 840060 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Dallas : University of Texas Southwestern Medical Center

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Dallas : UT Southwestern Medical Center

A clinical trial to evaluate treatments using ACTHAR Gel (ACTH) and IV steroids with oral taper for patients with Multiple Sclerosis

Dallas : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Dallas : University of Texas Southwestern Medical Center Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Houston : The Maxine Mesinger MS Clinic/Baylor College of Medicine Updated

A clinical research study of Tcelna and Placebo

Houston : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Houston : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Houston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Lubbock : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lubbock : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Mansfield : Investigational Site Number 840052 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

North Richland Hills : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Plano : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Round Rock : Central Texas Neurology Consultants, P.A.

A clinical study for patients with Multiple Sclerosis

Round Rock : Central Texas Neurology Updated

A clinical research study of Tcelna and Placebo

Round Rock : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Round Rock : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Round Rock : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Round Rock : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Round Rock : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

San Antonio : Innovative Clinical Trials, Bexar Diagnostic Medicine Assoc.

A clinical study for patients with Multiple Sclerosis

San Antonio : Integra Clinical Research, LLC Updated

A clinical research study of Tcelna and Placebo

San Antonio : Investigational Site Number 840028 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

San Antonio : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

San Antonio : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

San Antonio : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

San Antonio : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Sherman : Texoma Neurology Associates

A clinical study for patients with Multiple Sclerosis

Sherman : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Utah

Orem : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Salt Lake City : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Salt Lake City : Rocky Mountain MS Clinic

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Secondary Progressive Multiple Sclerosis or Clinically Isolated Syndrome

Salt Lake City : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Salt Lake City : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Salt Lake City : Rocky Mountain MS Research Group

Patients are needed to participate in a clinical research study for the treatment of Relapsing Remitting Multiple Sclerosis

Salt Lake City : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Salt Lake City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Salt Lake City : University of Utah Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Vermont

Burlington : Fletcher Allen Health Care - Neurology Service Updated

A clinical research study of Tcelna and Placebo

Burlington : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Burlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Virginia

Alexandria : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Alexandria : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Alexandria : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlottesville : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Charlottesville : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Charlottesville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlottesville : University of Virginia Charlottesville Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Henrico : Investigational Site Number 840070 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Henrico : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Newport News : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Newport News : Hampton Roads Neurology Updated

A clinical research study of Tcelna and Placebo

Newport News : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newport News : Teva Investigational Site 10330

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Norfolk : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Norfolk : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Norfolk : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Norfolk : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Richmond : Neurological Associates, Inc Updated

A clinical research study of Tcelna and Placebo

Richmond : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Roanoke : Biogen Idec Investigative Site Updated

A clinical research study of Peginterferon beta-1a and naproxen for the treatment of Relapsing-Remitting Multiple Sclerosis

Roanoke : Investigational Site Number 840017 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Roanoke : Teva Investigational Site 10311

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roanoke : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Roanoke : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Vienna : Investigational Site Number 840054 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Vienna : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Washington

Seattle : Benaroya Research Institute at Virginia Mason

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

Issaquah : Swedish Neuroscience Institute Updated

A clinical research study of Tcelna and Placebo

Issaquah : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kirkland : MS Center at Evergreen Health

A clinical research study for the treatment of Multiple Sclerosis

Seattle : Pacific Medical Centers

A clinical study for patients with Multiple Sclerosis

Seattle : Swedish Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Seattle : Swedish Neuroscience Institute Updated

A clinical research study of Tcelna and Placebo

Seattle : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Seattle : Virginia Mason Medical Center (VMMC)

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Seattle : Multiple Sclerosis Center, Swedish Neuroscience Institute

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Seattle : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Seattle :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Seattle : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Seattle :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Seattle : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Seattle : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Seattle : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Seattle : Teva Investigational Site 10335

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Seattle : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Seattle : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Seattle : Swedish Medical Center - Seattle Updated

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Seattle : Swedish Medical Center

Patients are needed to participate in a clinical research study of VX15/2503 and Placebo to evaluate Multiple Sclerosis

Tacoma : MultiCare Research Institute

A clinical study for patients with Multiple Sclerosis

Tacoma : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Tacoma : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tacoma : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Tacoma : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

West Virginia

Morgantown : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Morgantown : United BioSource Corporation

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis, Prenatal Exposure or Pregnancy

Wisconsin

Green Bay : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Milwaukee : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Milwaukee : Investigational Site Number 840038 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Milwaukee : Research Site

Patients are needed to participate in a clinical research study of Dimethyl fumarate (DMF) to evaluate Relapsing Forms of Multiple Sclerosis

Neenah : Investigational Site Number 840076 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Neenah : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Neenah : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingolimod and Disease Modifying therapy for the treatment of Relapsing Remitting Multiple Sclerosis

Albania

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Argentina

Buenos aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Buenos Aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Caba : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cordoba : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Guaymallen : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Salta : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Salta : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

San Miguel de Tucuman : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

San Miguel de Tucumán : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Australia

Adelaide : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Auchenflower : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Bedford Park : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Box Hill : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Box Hill : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Brisbane : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Brisbane Queensland : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Camperdown : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Fitzroy : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Geelong VIC : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Kanwal : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Kogarah : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Kogarah : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Liverpool : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Liverpool : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Melbourne : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

New Lambton Heights : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Parkville : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Parkville : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sydney : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Austria

Innsbruck : Teva Investigational Site 33013

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Klagenfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Linz : Investigational Site Number 040-001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Linz : Teva Investigational Site 33014

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Wien : Investigational Site Number 040-002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Wien : Teva Investigational Site 33016

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Wien : Teva Investigational Site 33015

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belarus

Gomel : Teva Investigational Site 68010

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Grodno : Teva Investigational Site 68013

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Teva Investigational Site 68009

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Teva Investigational Site 68012

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Teva Investigational Site 68008

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Vitebsk : Teva Investigational Site 68011

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belgium

Antwerpen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Brabant Wallon : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Brugge : Novartis Investigative Site

A clinical research study of Placebo and AIN457 for the treatment of Multiple Sclerosis

Brugge :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Brugge :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Brugge : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Brussels : Research Site

A clinical research study of MT-1303-Low, MT-1303-Middle, MT-1303-High and Placebo for the treatment of Relapsing-remitting Multiple Sclerosis

Brussels : Investigational Site Number 056001

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Brussels : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Brussels :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Brussels :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Bruxelles : Novartis Investigative Site

A clinical research study of Placebo and AIN457 for the treatment of Multiple Sclerosis

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bruxelles : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Charleroi : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Charleroi : Teva Investigational Site 37023

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Edegem : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Edegem : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gent : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hainaut : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

La Louviere : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Leuven : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Liege : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Liege :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Liège : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Limburg : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Luxembourg : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Melsbroek : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Melsbroek : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montegnée :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Montegnée :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Oost-Vlaanderen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Ottignies :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Ottignies :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Overpelt : Investigational Site Number 056002

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Overpelt : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Overpelt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sijsele : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sijsele-Damme : Investigational Site Number 056003

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Sijsele-Damme :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Sijsele-Damme :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sijsele-Damme : Teva Investigational Site 37024

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tinlot (Fraiture) : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

West-Vlaanderen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Bosnia and Herzegovina

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Mostar : Teva Investigational Site 69008

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sarajevo : Teva Investigational Site 69006

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tuzla : Teva Investigational Site 69009

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bulgaria

Pleven : Teva Investigational Site 59039

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Pleven : Teva Investigational Site 59040

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Plovdiv : Teva Investigational Site 59062

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Ruse : Teva Investigational Site 59061

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Shumen : Teva Investigational Site 59055

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Research Site

A clinical research study of MT-1303-Low, MT-1303-Middle, MT-1303-High and Placebo for the treatment of Relapsing-remitting Multiple Sclerosis

Sofia : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Sofia :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Sofia :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sofia : Teva Investigational Site 59048

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59044

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59042

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59063

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59038

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59052

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59041

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59045

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59057

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59054

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59043

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59059

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59058

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59050

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Stara Zagora : Teva Investigational Site 59049

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Varna : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Varna : Teva Investigational Site 59046

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Veliko Tarnovo : Teva Investigational Site 59051

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Veliko Tarnovo : Teva Investigational Site 59053

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Vidin : Teva Investigational Site 59060

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Canada

Bracebridge : South Muskoka Medical Clinic

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Burlington : Central Contact

A clinical study for patients with Multiple Sclerosis

Burnaby : Teva Investigational Site 11014

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Burnaby : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Calgary : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Edmonton : Research Site

A clinical research study of MT-1303-Low, MT-1303-Middle, MT-1303-High and Placebo for the treatment of Relapsing-remitting Multiple Sclerosis

Edmonton : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Edmonton : University of Alberta

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Edmonton : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Edmonton : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Gatineau : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Greenfield Park : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Greenfield Park : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Halifax : Biogen Idec Investigative Site Updated

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Halifax : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Halifax : Dalhousie MS Research Unit

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Halifax : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Halifax : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Halifax : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kingston : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Kingston : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Kingston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

London : Biogen Idec Investigative Site Updated

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

London : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

London : London Health Sciences Centre

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

London :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Montreal : Biogen Idec Investigative Site Updated

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Montreal : Montreal Neurological Institute and Hospital Updated

A clinical research study of Tcelna and Placebo

Montreal : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Montreal : McGill University - MNI

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Montreal : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Ottawa : University of Ottawa Updated

A clinical research study of Tcelna and Placebo

Ottawa : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Ottawa : The Ottawa Hospital

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Ottawa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Ottawa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ottawa : Teva Investigational Site 11015

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Ottawa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Ottawa :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Regina : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Saint John : Private Community Clinic Updated

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Saint John : Saint John Regional Hospital

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Saskatoon : Teva Investigational Site 11016

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Toronto : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Toronto : Sunnybrook Health Sciences Centre

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Toronto : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vancouver : Vancouver Coastal Health: University of British Columbia Hospital

A clinical study for patients with Multiple Sclerosis

Vancouver : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Vancouver : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Victoria : Biogen Idec Investigative Site Updated

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Chile

Santiago : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Santiago : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

China

Nanjing : Nanjing University Medical College Affiliated Drum Tower Hospital

A clinical research study of human umbilical cord mesenchymal stem cells for the treatment of Progressive Multiple Sclerosis or Neuromyelitis Optica.

Croatia

Osijek : Teva Investigational Site 60010

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Varazdin : Teva Investigational Site 60011

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Zagreb : Teva Investigational Site 60009

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Czech Republic

Brno : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Brno : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Brno : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Brno : Teva Investigational Site 54042

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Havirov : Teva Investigational Site 54043

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hradec Kralove : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Hradec Kralove : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Hradec Kralove : Teva Investigational Site 54047

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Jihlava : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Jihlava : Teva Investigational Site 54046

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Olomouc : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Olomouc : Teva Investigational Site 54044

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Ostrava - Vitkovice : Research Site

A Phase 1 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Pardubice : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Prague 5 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Praha : Research Site

A clinical research study of MT-1303-Low, MT-1303-Middle, MT-1303-High and Placebo for the treatment of Relapsing-remitting Multiple Sclerosis

Praha : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Praha : Teva Investigational Site 54041

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Praha 2 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Praha 2 : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Praha 2 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Teplice : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Teplice : Teva Investigational Site 54048

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Denmark

Arthus C : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Esbjerg : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Esbjerg : Research Site

A clinical trial to evaluate treatments for patients with Exercise

Glostrup : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

København Ø : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Odense : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Vejle : Research Site

A clinical trial to evaluate treatments for patients with Exercise

Estonia

Paernu : Teva Investigational Site 55005

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tallinn : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tallinn : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tallinn : Teva Investigational Site 55006

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tallinn : Teva Investigational Site 55008

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tartu : Teva Investigational Site 55007

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Finland

Hämeenlinna : Investigational Site Number 246004 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Helsinki : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Helsinski : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Jyväskylä : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Kuopio : Investigational Site Number 246005 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Oulu : Investigational Site Number 246006 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Oulu :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Tampere : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Turku : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Turku : Investigational Site Number 246001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Turku : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Turku :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Vantaa : Research Site

A clinical research study of MT-1303-Low, MT-1303-Middle, MT-1303-High and Placebo for the treatment of Relapsing-remitting Multiple Sclerosis

France

Agen Cedex : Investigational Site Number 250002 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Amiens cedex : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Angers : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Bayonne : Investigational Site Number 250006 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Bordeaux : Service de Neurologie - Pôle des Neurosciences Cliniques, CHU de Bordeaux.

A clinical study for patients with Multiple Sclerosis or Cognitive Rehabilitation

Bordeaux : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Bordeaux : Centre hospitaliere universitaire

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Bordeaux Cedex : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Bordeaux Cedex : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Bordeaux Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bron cedex : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Caen : Investigational Site Number 250008 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Caen : Centre hospitalier universitaire

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

CAEN Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Chambery : Investigational Site Number 250011 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Clermont-Ferrand : Centre hospitalier régional universitaire

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Clermont-Ferrand Cedex 1 : Teva Investigational Site 35075

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Dijon : Teva Investigational Site 35077

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Dijon : Centre hospitalier universitaire

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Le Kremlin Bicetre : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Lille : Teva Investigational Site 35073

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Lille : Centre hospitalier régional universitaire

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Lille : Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL)

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Lille Cedex : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Lille Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Limoges Cedex : Investigational Site Number 250019 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Lyon : Hospices civils de Lyon

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Marseille : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Marseille : Assistance Publique - Hôpitaux de Marseille

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Marseille cedex 05 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Marseille cedex 05 : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Marseille cedex 5 : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Metz-Tessy : Investigational Site Number 250022 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Montpellier : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montpellier : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Montpellier cedex 5 : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Nancy : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Nancy : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nancy : Centre hospitalier universitaire

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Nantes : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Nantes : Investigational Site Number 250027 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Nice : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Nice : Centre hospitalier universitaire (CHU), Nice

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Nimes : Investigational Site Number 250028 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Nimes : Centre hospitalier universitaire

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Nîmes : Teva Investigational Site 35079

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

PARIS Cedex 13 : Investigational Site Number 250016 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Paris Cedex 13 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Rennes : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

St Herblain : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Strasbourg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Strasbourg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Strasbourg : Centre hospitalier régional universtaire

Patients are needed to participate in a clinical research study of tears sampling to evaluate Primary Progressive Multiple Sclerosis

Toulouse cedex 9 : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Tourcoing : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Valenciennes : Investigational Site Number 250040 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

VICHY Cedex : Investigational Site Number 250013 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Georgia

Tbilisi :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Tbilisi : Teva Investigational Site 81018

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81016

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81019

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81017

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81014

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81015

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Germany

Aachen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aalen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Abensberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Achim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aichach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Altenburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Altenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Altenholz-Stift : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Alzenau : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Alzenau : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Andernach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Asbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aschaffenburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Aschaffenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Augsburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Homburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Honnef : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Krozingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Mergentheim : Investigational Site Number 276-003

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Bad Mergentheim : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Bad Mergentheim : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bad Mergentheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Mergentheim : Teva Investigational Site 32199

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bad Saarow : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Wilbad : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Bad Wildbad : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bamberg : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Bamberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bayreuth : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Berg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Berg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berg, Starnberger See : Teva Investigational Site 32195

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bergisch Gladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Morphosys Investigative Site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Teva Investigational Site 32198

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32176

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32186

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32174

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bielefeld : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bielefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bielefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Böblingen : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Böblingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Bochum : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Bochum : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis or Pregnancy

Bochum : Novartis Investigative Site

Patients are needed to participate in a clinical research study of Fingolimod to evaluate Multiple Sclerosis

Bogen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bonn : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Bonn : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Borna : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bottrop : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Braunschweig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bremen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bruchsal : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Buchholz : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Buchholz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Butzbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Celle : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Chemnitz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Darmstadt : Please contact the Merck KGaA Communication Center

A Phase 2 clinical study for patients with Multiple Sclerosis

Darmstadt : Please contact the Merck Communications Service for Recruiting locations

Patients are needed to participate in a clinical research study of Technical support for the RebiSmart™ device and Patient support program (MinSupport Plus) to evaluate Multiple Sclerosis or Relapsing-Remitting

Dillingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dillingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dortmund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dortmund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dresden : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Dresden : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Dresden : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Dresden : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dresden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dresden : Teva Investigational Site 32193

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Duesseldorf : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Duesseldorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Duesseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düren : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düsseldorf : Heinrich Heine Universität Düsseldorf

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düsseldorf :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Eltville : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Emden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Emmendingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erbach : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Erbach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Erbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erbach : Teva Investigational Site 32184

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Erfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erfurt : Teva Investigational Site 32189

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Erlangen : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Erlangen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Eschwege : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Flensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Frankfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Frankfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Frankfurt am Main : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Freiburg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Freiburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Freiburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Friedrichshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Fulda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Fulda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Geldern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gelnhausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gelsenkirchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gera : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gießen :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Gilching : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gladenbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Goettingen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Goettingen : Teva Investigational Site 32202

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Göttingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Greifswald : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Greifswald : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Greifswald :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Grevenbroich : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Griesheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gummersbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hagen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Halle : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Halle (Saale) : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Halle (Saale) : Teva Investigational Site 32196

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Halle/S. : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Teva Investigational Site 32181

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hamburg : Teva Investigational Site 32179

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hannover : Investigational Site Number 276-004

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Hannover : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Hannover : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Teva Investigational Site 32182

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Heidelberg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Heidelberg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Heidenheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hennigsdorf : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Hennigsdorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Hennigsdorf :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Herdecke : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Herford : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Herford : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hildesheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Homburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hoppegarten : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Idar-Oberstein : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Isselburg-Anholt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Itzehoe : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Itzehoe : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Itzehoe : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Jena : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Teva Investigational Site 32201

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Juelich : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kaiserslautern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kaltenkirchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kandel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Karlstadt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kassel : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Kassel : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Kassel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kiel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Klingenmünster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Koeln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Koeln-Longerich : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Koln : Teva Investigational Site 32183

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Köln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Köln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Köln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Königsbrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Korbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Krefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Krefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Landshut : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lappersdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Teva Investigational Site 32190

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Leverkusen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lohr am Main : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lübeck : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ludwigshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ludwigshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lüneburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lutherstadt Eisleben : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Magdeburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Magdeburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Magdeburg : Teva Investigational Site 32185

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Mainz : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Mannheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mannheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaferon, BAY 86-5046) to evaluate Multiple Sclerosis

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Marburg : Investigational Site Number 276-005

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Marburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Meisenheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Minden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Minden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mönchengladbach : Investigational Site Number 276-007

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Mönchengladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mönchengladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mosbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Muenchen : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Muenchen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Muenchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Muenster : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Muenster : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Muenster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mülheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

München : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

München : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Münster : Investigational Site Number 276-001

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Münster : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Münster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Nagold : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neuberg : Research Site

A clinical research study for the treatment of Multiple Sclerosis

Neuburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Neuburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neuruppin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neusäß : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neu-Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Nürnberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Oldenburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Oldenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Oldenburg i. Holstein : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrueck : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ostfildern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Paderborn : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Pforzheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Potsdam : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Fatigue in Multiple Sclerosis

Potsdam : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Potsdam : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Prien : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Prien : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Quakenbrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ravensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Recklinghausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Regensburg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Fatigue in Multiple Sclerosis

Regensburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Regensburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Regensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Remscheid : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Rostock : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Rostock : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Rostock : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Rostock : Teva Investigational Site 32191

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Rüdersdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Saarbrücken : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Schwendi : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Schwerin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Siegen : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Siegen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Singen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Sinsheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Solingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

St. Ingbert : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stade : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Stade : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stadtroda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stralsund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Telgte : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Teupitz : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Teupitz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Teupitz : Teva Investigational Site 32194

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Trier : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Troisdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Tübingen : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tübingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Tuebingen : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Ulm : Investigational Site Number 276-002

A clinical research study of teriflunomide HMR1726, cholestyramine and charcoal for the treatment of Multiple Sclerosis

Ulm : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Ulm : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Ulm : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ulm : Teva Investigational Site 32173

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Unterhaching : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Unterhaching : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wasserburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wendlingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wermsdorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Wermsdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wermsdorf : Teva Investigational Site 32197

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Westerstede : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Westerstede : Teva Investigational Site 32188

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Wiesbaden : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Wiesbaden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wiesbaden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wolfratshausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Würzburg : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Würzburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Würzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Würzburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Würzburg :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Zwickau : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Greece

Athens :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Athens :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Athens : Teva Investigational Site 63024

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Athens : Teva Investigational Site 63027

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Athens - GR : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Chaidari : Teva Investigational Site 63029

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Heraklion Crete : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Heraklion, Crete : Teva Investigational Site 63026

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Larissa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Thessaloniki :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Thessaloniki :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Thessaloniki : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Thessaloniki : Teva Investigational Site 63025

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Thessaloniki : Teva Investigational Site 63028

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hungary

Balassagyarmat : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Research Site

A clinical research study of MT-1303-Low, MT-1303-Middle, MT-1303-High and Placebo for the treatment of Relapsing-remitting Multiple Sclerosis

Budapest : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Budapest :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Budapest : Teva Investigational Site 51046

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Debrecen : Teva Investigational Site 51043

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Eger : Teva Investigational Site 51045

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Esztergom :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Esztergom : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gyor : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Kaposvar : Teva Investigational Site 51044

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Miskolc : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Miskolc : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nyiregyhaza : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nyíregyháza :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Nyíregyháza :

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Szeged : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Szekesfehervar : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Veszprem : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ireland

Cork : Biogen Idec Investigative Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis, Relapsing-Remitting or Relapsing Remitting Multiple Sclerosis

Dublin : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Dublin : Biogen Idec Investigative Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis, Relapsing-Remitting or Relapsing Remitting Multiple Sclerosis

Dublin 4 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dublin 9 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tralee : Biogen Idec Investigative Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis, Relapsing-Remitting or Relapsing Remitting Multiple Sclerosis

Israel

Haifa : Teva Investigational Site 80023

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Haifa : Teva Investigational Site 80024

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Jerusalem : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Jerusalem : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Ramat Gan : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Ramat Gan : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ramat Gan : Teva Investigational Site 80020

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tel Aviv : RedHill MS Clinical Trial Site 002

Patients are needed to participate in a clinical research study evaluating RHB-104 for the treatment of Relapsing Remitting Multiple Sclerosis

Tel Hashomer :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Tel-Aviv : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tel-Aviv : Teva Investigational Site 80021

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Zefat (Safed) : RedHill MS Clinical Trials Site 001

Patients are needed to participate in a clinical research study evaluating RHB-104 for the treatment of Relapsing Remitting Multiple Sclerosis

Italy

Ancona : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Ancona : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Baggiovara : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Bari : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Bari : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Bari : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bergamo : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Biella : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Bologna : Teva Investigational Site 30037

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Caltanissetta : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Castelfiorentino : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Catania : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Catania : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Catania :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Catania : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Catanzaro : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Cefalu : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Cefalu : Research Site

A clinical trial to evaluate treatments using Natalizumab for patients with Relapsing Remitting Multiple Sclerosis (RRMS)

Cefalù : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Cefalù : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Cefalù :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Cefalù : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cefalù (Palermo) : Teva Investigational Site 30030

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chieti : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Chieti : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Como : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Cuneo : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Empoli (FI) : Teva Investigational Site 30031

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Firenze : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Florence : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Foggia : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Gallarate : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Gallarate : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Gallarate : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Gallarate : Research Site

A clinical trial to evaluate treatments using Natalizumab for patients with Relapsing Remitting Multiple Sclerosis (RRMS)

Gallarate (Varese) : Teva Investigational Site 30029

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Genova : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Genova : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Genova : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Imperia : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Legnago : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Messina : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Messina : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Milan : Research Site

A clinical trial to evaluate treatments using Natalizumab for patients with Relapsing Remitting Multiple Sclerosis (RRMS)

Milan : Institute of Experimental Neurology

A Phase 3 clinical study for patients with Multiple Sclerosis

Milano : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Milano : Investigational Site Number 380001 Updated

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Milano :

A clinical trial to evaluate treatments using RPC1063 and placebo for patients with Relapsing Multiple Sclerosis

Milano : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Milano : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Milano : Teva Investigational Site 30023

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Modena : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Montichiari : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Montichiari : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Naples : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Naples : Investigational Site

Patients are needed to participate in a clinical research study of IFN beta 1 a + curcumin (BCM 95) and IFN beta-1a + placebo to evaluate Multiple Sclerosis

Napoli : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Napoli : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Napoli : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Napoli : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Napoli : Teva Investigational Site 30034

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Novara : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Padova : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Palermo : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Palermo : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Palermo : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Pavia : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Pavia : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Pavia :

Patients are needed to participate in a clinical research study of Several diagnostic procedures to evaluate Multiple Sclerosis

Pisa : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Pozzilli : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Roma : Research Site

A clinical research study of MT-1303-Low, MT-1303-Middle, MT-1303-High and Placebo for the treatment of Relapsing-remitting Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod and Interferon beta 1b for patients with Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Roma : Teva Investigational Site 30026

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30035

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30025

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30028

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Rome : Research Site

A Clinical Study of the Efficacy of Natalizumab on Reducing Disability Progression in Subjects With SPMS

Rome : Research Site

A clinical trial to evaluate treatments using Natalizumab for patients with Relapsing Remitting Multiple Sclerosis (RRMS)

San Donato Milanese : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Verona : Novartis Investigative Site

Patients are needed to participate in a clinical research study evaluating Fingoliomod and Interferon beta 1a or interferon beta 1b or Glatiramer Acetate for the treatment of Relapsing Remitting Multiple Sclerosis

Japan

Chiba : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Chiba : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Chiba, : Research Site

A clinical study for patients with Multiple Sclerosis

Chiba, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Ehime : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Fuchu : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Fukuoka : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Fukuoka, : Research Site

A clinical study for patients with Multiple Sclerosis

Fukuoka, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Hiroshima, : Research Site

A clinical study for patients with Multiple Sclerosis

Hiroshima, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Hokkaido : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Hyogo : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Ibaraki : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Ishikawa : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kanagawa : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kawagoe, : Research Site

A clinical study for patients with Multiple Sclerosis

Kawagoe, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Kodaira, : Research Site

A clinical study for patients with Multiple Sclerosis

Kodaira, : University of British Columbia

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Kyoto : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kyoto, : Research Site

A clinical study for patients with Multiple Sclerosis

Kyoto, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Kyoto, : London Health Sciences Centre

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Miyagi : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Morioka : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Morioka, : Research Site

A clinical study for patients with Multiple Sclerosis

Morioka, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Niigata : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Niigata : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Niigata, : Research Site

A clinical study for patients with Multiple Sclerosis

Niigata, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Osaka : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Osaka : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Osaka, : Research Site

A clinical study for patients with Multiple Sclerosis

Osaka, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Osaka, : Univ of Calgary / Foothills MC

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Osaka-city : Novartis Investigative Site

A clinical research study of Placebo and AIN457 for the treatment of Multiple Sclerosis

Saitama : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Sapporo : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Sapporo, : Research Site

A clinical study for patients with Multiple Sclerosis

Sapporo, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Sapporo-Shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Sendai, : Research Site

A clinical study for patients with Multiple Sclerosis

Sendai, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Suita, : Research Site

A clinical study for patients with Multiple Sclerosis

Suita, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Tokorozawa, : Research Site

A clinical study for patients with Multiple Sclerosis

Tokorozawa, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Tokyo : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Tokyo : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Tokyo, : Research Site

A clinical study for patients with Multiple Sclerosis

Tokyo, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Tsukuba, : Research Site

A clinical study for patients with Multiple Sclerosis

Tsukuba, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Ube, : Research Site

A clinical study for patients with Multiple Sclerosis

Ube, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Yamaguchi : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Yamaguchi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Yokohama, : Research Site

A clinical study for patients with Multiple Sclerosis

Yokohama, : Research Site

A Phase 2/Phase 3 clinical study for patients with Multiple Sclerosis

Kazakhstan

Many Locations : Updated

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Korea, Republic of

Daegu : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Goyang, GYEONGGI-DO : Teva Investigational Site 87001

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gyeonngi : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Research Site Updated

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Teva Investigational Site 87002

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Seoul : Teva Investigational Site 87003

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Latvia

Riga : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Riga : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Riga : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Riga : Teva Investigational Site 56005

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Riga : Teva Investigational Site 56006

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Lithuania

Kaunas : Research Site

A clinical research study of MT-1303-Low, MT-1303-Middle, MT-1303-High and Placebo for the treatment of Relapsing-remitting Multiple Sclerosis

Kaunas : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Kaunas : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Klaipeda : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vilnius : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Macedonia, The Former Yugoslav Republic of

Skopje : Teva Investigational Site 65012

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Skopje : Teva Investigational Site 65010

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Skopje : Teva Investigational Site 65011

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Malaysia

Kuala Lumpur : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Kuala Lumpur : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Mexico

Aguascalientes : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Chihuahua : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Chihuahua : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Mexico City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Monterrey : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Moldova, Republic of

Chisinau : Teva Investigational Site 70005

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chisinau : Teva Investigational Site 70008

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chisinau : Teva Investigational Site 70006

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)